Gill Coombes

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

Tom Treasure, Loı̈c Lang-Lazdunski, David Waller et al. · The Lancet Oncology · 2011 · 706 citations · Full text

Excision Margins in High-Risk Malignant Melanoma

Joseph Thomas, Julia Newton‐Bishop, Roger A’Hern et al. · New England Journal of Medicine · 2004 · 494 citations

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

Stephen Johnston, Lucy Kilburn, David Dodwell et al. · The Lancet Oncology · 2013 · 272 citations · Full text

Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.

R. Charles Coombes, Judith M. Bliss, J. Wils et al. · Journal of Clinical Oncology · 1996 · 170 citations

Epirubicin Plus Tamoxifen Versus Tamoxifen Alone in Node-Positive Postmenopausal Patients With Breast Cancer: A Randomized Trial of the International Collaborative Cancer Group

J. Wils, Judith M. Bliss, M. Marty et al. · Journal of Clinical Oncology · 1999 · 82 citations